关注
Min Xie
Min Xie
The Gladstone Institutes
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Small molecules enhance CRISPR genome editing in pluripotent stem cells
C Yu, Y Liu, T Ma, K Liu, S Xu, Y Zhang, H Liu, M La Russa, M Xie, S Ding, ...
Cell stem cell 16 (2), 142-147, 2015
4922015
Conversion of human fibroblasts into functional cardiomyocytes by small molecules
N Cao, Y Huang, J Zheng, CI Spencer, Y Zhang, JD Fu, B Nie, M Xie, ...
Science 352 (6290), 1216-1220, 2016
3982016
Organocatalytic asymmetric transformations of modified Morita–Baylis–Hillman adducts
TY Liu, M Xie, YC Chen
Chemical Society Reviews 41 (11), 4101-4112, 2012
3972012
Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
T Xu, KM Stewart, X Wang, K Liu, M Xie, JK Ryu, K Li, T Ma, H Wang, L Ni, ...
Nature 548 (7666), 228-233, 2017
3122017
Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening
C Wang, ME Ward, R Chen, K Liu, TE Tracy, X Chen, M Xie, PD Sohn, ...
Stem cell reports 9 (4), 1221-1233, 2017
2942017
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone
Z Cui, J Crane, H Xie, X Jin, G Zhen, C Li, L Xie, L Wang, Q Bian, T Qiu, ...
Annals of the rheumatic diseases 75 (9), 1714-1721, 2016
2302016
A novel YAP1 inhibitor targets CSC-enriched radiation-resistant cells and exerts strong antitumor activity in esophageal adenocarcinoma
S Song, M Xie, AW Scott, J Jin, L Ma, X Dong, HD Skinner, RL Johnson, ...
Molecular cancer therapeutics 17 (2), 443-454, 2018
1692018
Progress in the reprogramming of somatic cells
T Ma, M Xie, T Laurent, S Ding
Circulation research 112 (3), 562-574, 2013
1602013
Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens
C Jin, L Yang, M Xie, C Lin, D Merkurjev, JC Yang, B Tanasa, S Oh, ...
Proceedings of the National Academy of Sciences 111 (25), 9235-9240, 2014
752014
YAP1-mediated CDK6 activation confers radiation resistance in esophageal cancer–Rationale for the combination of YAP1 and CDK4/6 inhibitors in esophageal cancer
F Li, Y Xu, B Liu, PK Singh, W Zhao, J Jin, G Han, AW Scott, X Dong, ...
Clinical Cancer Research 25 (7), 2264-2277, 2019
622019
Chemical modulation of cell fate in stem cell therapeutics and regenerative medicine
K Liu, C Yu, M Xie, K Li, S Ding
Cell chemical biology 23 (8), 893-916, 2016
572016
(R)‐3‐Methyl‐3‐Phenyl‐1‐Pentene Via Catalytic Asymmetric Hydrovinylation
CR Smith, A Zhang, DJ Mans, TV RajanBabu, SE Denmark, M Xie
Organic Syntheses, 248-266, 2008
462008
Lewis acid-promoted conjugate addition of dienol silyl ethers to nitroalkenes: Synthesis of 3-substituted azepanes
M Xie, SE Denmark
The Journal of organic chemistry 72 (18), 7050-7053, 2007
452007
Concise review: chemical approaches for modulating lineage-specific stem cells and progenitors
T Xu, M Zhang, T Laurent, M Xie, S Ding
Stem Cells Translational Medicine 2 (5), 355-361, 2013
402013
Patient-specific induced pluripotent stem cells for disease modeling and phenotypic drug discovery: miniperspective
S Tang, M Xie, N Cao, S Ding
Journal of medicinal chemistry 59 (1), 2-15, 2016
362016
Small molecules for cell reprogramming and heart repair: progress and perspective
M Xie, N Cao, S Ding
ACS chemical biology 9 (1), 34-44, 2014
322014
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
JA Ajani, JS Estrella, Q Chen, AM Correa, L Ma, AW Scott, J Jin, B Liu, ...
British journal of cancer 118 (1), 52-61, 2018
262018
Pharmacological reprogramming of somatic cells for regenerative medicine
M Xie, S Tang, K Li, S Ding
Accounts of Chemical Research 50 (5), 1202-1211, 2017
202017
Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia
MA Telpoukhovskaia, K Liu, FA Sayed, JI Etchegaray, M Xie, L Zhan, Y Li, ...
Scientific reports 10 (1), 13688, 2020
192020
Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells
K Saydaminova, R Strauss, M Xie, J Bartek, M Richter, R van Rensburg, ...
Cancer biology & therapy 17 (10), 1079-1088, 2016
112016
系统目前无法执行此操作,请稍后再试。
文章 1–20